As the pharmaceutical industry contends with growing financial pressures, we examine its strategic outlook for 2024. How does the sector intend to align with projected commercial objectives while continuing to meet patient needs and what are the implications for forecasting teams?
London, UK & Boston, MA, Jan. 10, 2024 - Evaluate, a Norstella company, announced today the acquisition of J+D Forecasting, a leading provider of forecasting solutions for the pharmaceutical industry.
Epidemiology data plays an essential role in market estimation and forecasting within pharmaceutical and biotech organizations. Understanding disease prevalence helps to plan and evaluate strategies to prevent or manage illness and guide new drug development and demand planning.
Patient flow forecasting can have a significant impact on patient outcomes. Specialist forecasting software can support pharma companies in achieving accurate predictions for enhanced outcomes.
Here, we discuss the concept of patient flow forecasting, its methodology, common statistical models and methods, and how dedicated software is essential in mastering this complex forecasting technique.
Navigating change management in pharmaceutical forecasting can be a daunting challenge, but with FC365 these challenges are met head-on. Discover how this innovation is helping teams embrace technological advancements within forecasting.
"Digital transformation in pharma has become a critical imperative to address industry challenges and unlock opportunities for enriched patient care, innovation, and efficiency through the power of technology."